ZION
57
-3
SPG
53
2
UHS
52
2
PBI
59
-7
MU
42
7
KR
57
-6
PLD
43
-2
CCL
68
-2
MCO
74
-3
IR
55
-3
FAST
46
-3
AZO
62
4
WBA
64
4
AKAM
59
-2
STZ
54
2
RL
75
3
NKE
37
-3
HAS
32
-5
DRI
48
3
KEY
31
2
ZION
57
-3
SPG
53
2
UHS
52
2
PBI
59
-7
MU
42
7
KR
57
-6
PLD
43
-2
CCL
68
-2
MCO
74
-3
IR
55
-3
FAST
46
-3
AZO
62
4
WBA
64
4
AKAM
59
-2
STZ
54
2
RL
75
3
NKE
37
-3
HAS
32
-5
DRI
48
3
KEY
31
2
Financhill
Back

Larimar Therapeutics Stock Predictions

The dark truth about AI

Click here to learn more...
Sell
47

LRMR
Larimar Therapeutics

Last Price:
6.17
Seasonality Move:
30.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Larimar Therapeutics Stock Forecast

  • Over the next 52 weeks, Larimar Therapeutics has on average historically fallen by 5.8% based on the past 10 years of stock performance.
  • Larimar Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Larimar Therapeutics Stock Undervalued?
    The current Larimar Therapeutics [LRMR] share price is $6.17. The Score for LRMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • LRMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Larimar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Larimar Therapeutics has on average historically fallen by 5.8% based on the past 10 years of stock performance.

Larimar Therapeutics Stock Rating

Sell
47
Larimar Therapeutics (LRMR) is a Sell

Is Larimar Therapeutics overpriced?

  • Larimar Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Larimar Therapeutics Stock Price History

Is LRMR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
larimartx.com

52-Week Data

52-Week High:
13.68
52-Week Low:
3.80

Prediction Charts

Market Cap:
393.69M
Price in USD:
6.17
Volume:
430.86K
Beta:
0.51

Technical Analysis

SMA50:
7.15
SMA100:
7.38
SMA200:
7.80
52-Wk Change:
51.23%

Stock Predictions

  • Is Larimar Therapeutics stock public?
    Yes, Larimar Therapeutics is a publicly traded company.
  • What is the Larimar Therapeutics stock quote today?
    The Larimar Therapeutics stock price is 6.17 USD today.
  • How to buy Larimar Therapeutics stock online?
    You can buy Larimar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 6.28 6.33 6.53 6.25
Nov-26 6.53 6.18 6.53 6.13
Nov-27 6.26 6.64 6.66 6.07
Nov-29 6.66 6.33 6.69 6.26
Dec-2 6.35 6.20 6.51 6.15
Dec-3 6.15 6.07 6.36 6.00
Dec-4 6.10 6.08 6.29 5.90
Dec-5 6.04 6.02 6.17 5.94
Dec-6 6.01 6.46 6.50 6.01
Dec-9 6.47 6.76 6.91 6.45
Dec-10 6.85 6.57 6.86 6.33
Dec-11 6.60 6.50 6.62 6.06
Dec-12 6.43 6.11 6.48 5.81
Dec-13 6.20 6.17 6.31 6.01

Larimar Therapeutics Earnings

Larimar Therapeutics Earnings Report: Per Share Larimar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Larimar Therapeutics Forecast Revenue Growth

Larimar Therapeutics Stock Analysis: Historical quarterly revenues per share for Larimar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.40 per share.

* Larimar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.